SCHEMBL7674579

SCHEMBL7674579

CN1CCC2(CC1)c1ccccc1Oc1ccc(Cl)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.47
DRD4 P21917 5/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C19 P33261 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
HRH1 P35367 5/20 0.46
HRH4 Q9H3N8 5/20 0.46
HTR2A P28223 3/20 0.46
HTR2B P41595 3/20 0.46
HRH2 P25021 3/20 0.46
CHRM2 P08172 2/20 0.46
HTR1A P08908 2/20 0.46
ADRA2A P08913 2/20 0.46
ADRA2B P18089 2/20 0.46
ADRA2C P18825 2/20 0.46
DRD1 P21728 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7681805 0.93 HRH4 (0.45) DRD2DRD4CYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL11400430 0.91 HRH4 (0.44) DRD2DRD4CYP1A2CYP3A4CYP2D6
SCHEMBL7675241 0.87 DRD4 (0.46) DRD2DRD4CYP1A2HRH4DRD1
SCHEMBL30089988 0.87 DRD4 (0.46) DRD2DRD4CYP1A2HRH4DRD1
Hydrochloric Acid SCHEMBL7673355 0.85 DRD4 (0.44) DRD2DRD4CYP1A2HRH4CHRM3
SCHEMBL11248897 0.85 HRH1 (0.56) DRD2DRD4CYP1A2CYP3A4CYP2D6
Bromide SCHEMBL11473841 0.84 HRH1 (0.56) DRD2DRD4CYP1A2CYP3A4CYP2D6
SCHEMBL7673324 0.82 CCR1 (0.47) DRD2DRD4CYP2D6HRH1HTR2A
SCHEMBL7675510 0.80 HTR2C (0.46) DRD2DRD4CYP1A2CYP3A4CYP2D6
SCHEMBL11246209 0.76 HRH1 (0.40) DRD2DRD4CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6387893-B1 ADRENERGIC BLOCKING AGENT; BENIGN PROSATATIC HYPERPLASIA MERCK & CO., INC. 2002-05-14 US disclosed